Proteins destined for the peroxisome matrix or membrane possess distinct targeting signals that engage signal sequence receptors to drive their transport to their final subcellular destination. Peroxisomal targeting signal 1 (PTS1) and 2 (PTS2) are well characterized as signaling the import from the cytosol into the peroxisomal matrix of soluble peroxisomal enzymes. PTS1 is a peptide with a three-amino acid sequence of serine (S), lysine (K), and leucine (L) (SKL motif) in the extreme COOH terminus of the protein. However, recent studies revealed that PTS1 has a wide range of variants with respect to the length, sequences, and position of the amino acid residues. The membrane protein is considered to be localized through a different mechanism because the SKL motif has never been found in peroxisomal membrane proteins. The soluble protein is thought to have the main signal for localization because the SKL motif exists in most soluble peroxisomal proteins. PTS1 signals bind to their receptor, Pex5p, for the protein to be targeted to peroxisome. PTS2 is located at or near the NH 2 termini of some peroxisomal matrix proteins with a wide range of consensus sequences. PTS2 interacts with their import receptor, Pex7p, and the proteins with PTS2 signals are targeted to peroxisome.
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Alanine : glyoxylate aminotransferase (AGT) is a liver-specific peroxisomal enzyme. Deficiency in AGT causes primary hyperoxaluria type I (PH1), which is a rare autosomal recessive disease. AGT is a protein composed of 392 amino acids (a.a.), and it has a similar lysine (K), lysine (K), and leucine (L) (KKL) amino acid sequence to that of the SKL motif in the extreme COOH terminus. It was reported that the COOH-terminal tripeptide KKL of human AGT is necessary as the peroxisomal targeting sequence. However, the peroxisomal targeting signal of AGT and the mechanism of targeting to peroxisome are still unclear. [1] [2] [3] [4] [5] In the present paper, human-origin AGT was targeted into peroxisome at specific regions of the AGT (59-66 a.a. and 389-392 a.a.) in HeLa cells using enhanced green fluorescent protein (eGFP)-tagged AGT and deletion mutants. In the three-dimensional structural model their sites were separately located on the surface of the AGT protein.
MATERIALS AND METHODS

Construction of Plasmids
The expression vector for the eGFP-tagged full-length AGT1-392 a.a. (AGT fused to the COOH terminus of eGFP), pEGFPAGT1-392, was constructed by inserting the cDNA fragment of AGT PCR-amplified from the expression vector of the human-origin AGT, pTrcHis2AGT (a gift from Dr. S. Hirose, Fukuoka University, Fukuoka, Japan) into the EcoRI site of the multi-cloning site (MCS) of the expression vector of eGFP, pEGFP-C1 (Clontech Co., Palo Alto, CA, U.S.A.). The expression vectors of the eGFP-tagged AGT deletion mutants were constructed by modifying pEGFPAGT1-392. The full-length AGT and deletion mutants used in the paper are schematically shown in Fig. 1 .
Cell Culture and Transfection HeLa cells and COS-7 cells were purchased from the Institute of Physical and Chemical Research (RIKEN) (Wako, Japan). They were routinely maintained in Dulbecco's modified Eagle's minimal essential medium (DMEM) (Sigma Co., St. Louis, MO, U.S.A.) supplemented with 10% fetal bovine serum (FBS) (Medical & Biological Laboratories Co., Nagoya, Japan). The cells were maintained in 5% CO 2 at 37°C.
Immunostaining of the Cells HeLa cells and COS-7 cells grown on glass cover slips were fixed in 4% paraformaldehyde for 1 h at room temperature. After permeabilization with 0.1% Triton X-100 in PBS for 10 min at room temperature, the cells were blocked with 2% FBS in PBS and incubated with the anti-human catalase antibody or preimmune serum and then cy3.5-conjugated goat IgG to rabbit immunoglobulin (IgG, IgA, and IgM) (ICN Pharmaceuticals, Aurora, OH, U.S.A.). They were observed on a confocal laser-scanning microscopy as reported below.
Observation of Subcellular Localization in the Cells by Confocal Laser-Scanning Microscopy HeLa cells and COS-7 cells in 35-mm dishes (10.8 cm 2 ) were grown on glass cover slips in DMEM supplemented with 10% FBS, and the plasmids (1 mg pEGFP-C1 or pEGFPAGT derivatives) were transiently cotransfected using lipofectamine2000 (Invitrogen Co., CA, U.S.A.) and incubated for 48 h. The cells were washed with PBS and fixed in 4% paraformaldehyde for 1 h. After the cover slips were mounted on glass slides, the cells were viewed on a confocal laser-scanning microscope Model Fluoview FV300 (Olympus Co., Tokyo, Japan).
Three-Dimensional Structural Model of AGT A molecular model of the AGT was prepared with the MolFeat v2.0 program (FiatLux Co., Tokyo, Japan) using Protein Data Bank (PDB) data for AGT on the basis of X-ray analysis and structure models. 6) 
RESULTS AND DISCUSSION
The peroxisomal targeting signals of AGT were examined using the expression vectors of the eGFP-tagged AGT (fulllength or deletion mutants) (Fig. 1) . After the expression vectors were introduced to HeLa cells, the green fluorescence of eGFP was observed with a confocal laser-scanning microscope. Representative data indicating whether or not eGFP or eGFP-tagged AGT derivatives should be targeted into peroxisome are shown in Fig. 2 . The results are summarized using plus (ϩ) or minus (Ϫ) signs on the right-hand side of Fig. 1 . In HeLa cells transfected with pEGFP-C1, the green fluorescence of eGFP was observed in cytosol and nuclei stained with propidium iodide (P.I.) (red fluorescence) (Fig. 2A) . The green fluorescence of the eGFP-tagged full-length AGT was co-localized with the peroxisomal marker catalase (red fluorescence of cy3.5), suggesting that the eGFP-tagged AGT was correctly targeted into peroxisome (Fig. 2B) .
The truncated mutant missing the NH 2 -terminal amino acids, AGT197-392 a.a., was not targeted into peroxisome by transfection with a lower dose (0.5 mg/dish) (data not shown) and hardly targeted even by a higher transfection dose (1 or 2 mg/dish) (see the multiple cell image at the lower magnification (ϫ20) in Fig. 2C ). It has been reported that human AGT may possess ancillary targeting information (PTS1A) in AGT283-392 a.a. (possibly 324-345 a.a.).
4)
The authors expressed GFP-tagged AGT283-392 a.a. in COS-1 cells, targeting into peroxisome. In COS-7 cells transfected with pEGFPAGT197-392, eGFP-tagged AGT197-392 a.a. was also targeted efficiently into peroxisome (data not shown). As mentioned below, eGFP-tagged AGTD221-388 a.a. lacking the PTS1A sequence was targeted into peroxisome in HeLa cells. The targeting signal in AGT324-345 a.a. is very weak and not essential in HeLa cells. Taken together, our findings demonstrate that AGT could hold the targeting signal on AGT1-196 a.a. To determine the amino acid sequence in the targeting signal on AGT1-196 a.a, the deletion mutants of AGT {AGT34-392 a.a., 48-392 a.a. (Fig. 2D), 54-392 a.a., 56-392 a.a., 58-392 a.a., 59-392 a.a., 60-392 a.a., 65-389 a.a., 89-392 a.a. (Fig. 2E) , D66-229 a.a., and D67-229 a.a.} were examined (Fig. 1).  AGTs34-392 a.a., 48-392 a.a., 54-392 a. a., and 56-392 a.a. were as efficiently targeted into peroxisome as fulllength AGT. AGT58-392 a.a. was not efficiently targeted. AGT59-392 a.a. was practically not targeted. AGT 89-392 a.a. was not targeted. The amino acid sequence containing AGT59-66 a.a. (8 amino acids) was necessary, and it was designated as the peroxisomal targeting signal a, PTSa. The PTS2 signal is located at or near the NH 2 terminus of peroxisomal matrix proteins.
1) However, the amino acid sequence of PTSa is different from the consensus amino acid sequences of PTS2. A single amino acid mutation in the NH 2 -terminal 20 amino acids of AGT enabled the polypeptide to direct mitochondria targeting. 5) In the present study, deletion of the NH 2 -terminal amino acids of AGT did not influence the subcellular localization of AGT. PTSa is different from these amino acids.
The truncated mutant missing the COOH-terminal amino acids, AGT1-216 a.a. was not targeted into peroxisome (Fig. 2F) . AGT could hold another targeting signal on AGT217-392 a.a. The amino acid sequence in the targeting signal on AGT217-392 a.a. was examined. The deletion mutants {AGT1-353 a.a. and AGT1-389 a.a. (DKKL) (Fig. 2G )} were not targeted into peroxisome. This observation is consistent with the results of a previous paper. 4) There is a targeting signal in the extreme COOH terminus. The signal in the COOH terminus of AGT was examined as described above using a deletion mutant. AGTD221-390 a.a. (with KL) and AGTD221-389 a.a. (with KKL) (Fig. 2I) were not targeted into peroxisome. AGTD221-388 a.a. (with KKKL) (Fig. 2H) and AGTD221-386 a.a. (with CP-KKKL) were targeted. The peptide of AGT389-392 a.a. (4 amino acids, KKKL, but not KKL) was necessary and was designated as peroxisomal targeting signal b, PTSb. AGT58-392 a.a., AGTD67-229 a.a., and AGTD221-386 a.a. were targeted into peroxisome as reported above, suggesting that AGT does not bear any peroxisomal targeting signals on AGT1-57 a.a., AGT67-229 a.a., or AGT221-388 a.a. AGTD67-388 a.a. (no amino acids between PTSa and PTSb) was not targeted into peroxisome. AGTD67-229 a.a. and AGTD221-388 a.a. were targeted as mentioned above. AGT may require some spacer amino acids between PTSa and PTSb.
The three-dimensional structural model of AGT was as- sembled using the MolFeat program on the basis of X-ray analysis and structure models 6) (Fig. 3) . As shown in the model, PTSa and PTSb are separately located on the surface of the AGT protein. Therefore, they could interact with each peroxisomal targeting factor, and the AGT protein could be introduced into peroxisome. PTSa (AGT59-66 a.a.) is positioned at the COOH-terminal half-end of the a-helical structure on AGT49-66 a.a. The peptide chain of AGT383-392 a.a. containing PTSb (AGT389-392 a.a.) at the extreme COOH terminus could be flexible. 
